About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Seattle | 11,380 Studies Near You

Clinical TrialsSeattle

Clinical Trials in Seattle

Discover 11,380 clinical trials near Seattle, Washington. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 6061-6080 of 11,380 trials

CompletedVortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual DysfunctionThe purpose of this study is to evaluate the effects of Vortioxetine (Lu AA21004), once daily (QD), compared with escitalopram on sexual functioning.NCT01364649·Birmingham, Alabama and 61 others

Find Trials by Condition in Seattle

Breast Cancerin Seattle Lung Cancerin Seattle Prostate Cancerin Seattle Colorectal Cancerin Seattle Melanomain Seattle Leukemiain Seattle Lymphomain Seattle Pancreatic Cancerin Seattle Ovarian Cancerin Seattle Brain Cancerin Seattle Diabetes

Data from ClinicalTrials.govTerms

RecruitingStudy of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System TumorsThis is a Phase 1 study of central nervous system (CNS) locoregional adoptive therapy with autologous CD4+ and CD8+ T cells lentivirally transduced to express a B7H3-specific…NCT04185038·Seattle, Washington

Active not recruitingStudy of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)The Phase 2 study is a multicenter, open-label study of RP1 to further investigate safety and to estimate the efficacy of RP1 at the RP2D in combination with nivolumab in patients…NCT03767348·Birmingham, Alabama and 50 others

CompletedA Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 DiabetesThe GRADE Study is a pragmatic, unmasked clinical trial that will compare commonly used diabetes medications, when combined with metformin, on glycemia-lowering effectiveness and…NCT01794143·Birmingham, Alabama and 35 others

RecruitingA Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate CancerThe purpose of Parts 1, 2A, and 2B of the study is to determine the recommended regimen for Phase 2 (RP2Rs) of combination of JNJ-87189401 with JNJ-78278343 and the purpose of…NCT06095089·Aurora, Colorado and 19 others

CompletedCOntrolled MyeloFibrosis Study With ORal JAK Inhibitor Treatment: The COMFORT-I TrialThis was a randomized, double-blind study comparing the efficacy and safety of ruxolitinib (INCB018424) tablets to matching placebo tablets in patients diagnosed with…NCT00952289·Birmingham, Alabama and 111 others

CompletedA Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)This is a Phase 2, multicenter study designed to evaluate the efficacy and safety of trastuzumab emtansine administered as a single-agent in participants with HER2-positive (HER2…NCT02289833·Jacksonville, Florida and 22 others

CompletedFacilitating Communication StudyThis study is a randomized clinical trial of an intervention to improve outcomes for patients and their family by using ICU nurse facilitators to support, model, and teach…NCT03721952·Seattle, Washington and 2 others

TerminatedStudy of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes MellitusThis study will assess the safety and efficacy of secukinumab on the preservation of pancreatic beta cells in patients with newly-diagnosed type 1 diabetes mellitus.NCT02044848·New York, New York and 1 other

CompletedAbrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative ColitisThe primary objective of this study is to evaluate the effect of abrilumab on induction of remission in adults with moderate to severe ulcerative colitis after 8 weeks of…NCT01694485·Birmingham, Alabama and 122 others

TerminatedStudy of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based ChemotherapyThis Phase 3 study will compare the efficacy of talabostat plus pemetrexed to pemetrexed plus placebo in patients with Stage IIIB/IV NSCLC who have failed a platinum-based…NCT00290017·Huntsville, Alabama and 100 others

WithdrawnEvaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124This clinical investigation is a substudy within GS-US-416-2124, IND 129570, which is A Phase 2, Double-Blind, Randomized Study Evaluating the Safety, Tolerability, and Efficacy…NCT03087968·Coronado, California and 12 others

CompletedIMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum WomenThis study was a randomized strategy trial conducted among women who received highly active antiretroviral therapy (HAART) during pregnancy for purposes of prevention of…NCT00955968·Alhambra, California and 49 others

CompletedA Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque PsoriasisTh purpose of the study is to evaluate the dose response of JNJ-77242113 in efficacy at Week 16 in participants with moderate-to-severe plaque psoriasis.NCT05223868·Phoenix, Arizona and 75 others

CompletedSurgical Treatment for Hallux RigidusThe purpose of this study is to examine the long-term outcomes for the surgical treatment of end stage degeneration in the big toe joint.NCT01048450·Greeley, Colorado and 5 others

Active not recruitingA Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ LeukemiaPatients with relapsed or refractory leukemia often develop resistance to chemotherapy and some patients who relapse following CD19 directed therapy relapse with CD19 negative…NCT03330691·Los Angeles, California and 4 others

CompletedRed and Processed Meat Effects on the Metabolome and MicrobiomeThis controlled feeding trial will identify biomarkers in the metabolome and microbiome that may differ when consuming a healthy diet with or without red and processed meat.NCT05274906·Seattle, Washington

CompletedVEGF Trap in Treating Patients With Recurrent or Persistent Endometrial CancerThis phase II trial is studying the side effects and how well VEGF Trap works in treating patients with recurrent or persistent endometrial cancer.NCT00462826·Hartford, Connecticut and 66 others

CompletedBreast Cancer Surveillance ConsortiumThe Breast Cancer Surveillance Consortium (BCSC) database contains data from 1994-2009 on breast cancer screening, quality, and outcomes, and its main goal is to advance breast…NCT01831778·Seattle, Washington

TerminatedStudy For Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M)This is a Phase 1/2 study of PF-06747775 as a single agent and in combination with other cancer treatments in patients with advanced EGFRm NSCLC.NCT02349633·La Jolla, California and 14 others

PreviousPage 304 of 569Next

in Seattle

Heart Diseasein Seattle